230 related articles for article (PubMed ID: 20738829)
1. Platelet apoptosis and activation in platelet concentrates stored for up to 12 days in plasma or additive solution.
Cookson P; Sutherland J; Turner C; Bashir S; Wiltshire M; Hancock V; Smith K; Cardigan R
Transfus Med; 2010 Dec; 20(6):392-402. PubMed ID: 20738829
[TBL] [Abstract][Full Text] [Related]
2. Cryopreservation of buffy-coat-derived platelet concentrates in dimethyl sulfoxide and platelet additive solution.
Johnson LN; Winter KM; Reid S; Hartkopf-Theis T; Marks DC
Cryobiology; 2011 Apr; 62(2):100-6. PubMed ID: 21241687
[TBL] [Abstract][Full Text] [Related]
3. Impact of pathogen reduction technology and storage in platelet additive solutions on platelet function.
Galan AM; Lozano M; Molina P; Navalon F; Marschner S; Goodrich R; Escolar G
Transfusion; 2011 Apr; 51(4):808-15. PubMed ID: 20977485
[TBL] [Abstract][Full Text] [Related]
4. Storage of buffy-coat-derived platelets in additive solutions at 4 degrees C and 22 degrees C: flow cytometry analysis of platelet glycoprotein expression.
Sandgren P; Hansson M; Gulliksson H; Shanwell A
Vox Sang; 2007 Jul; 93(1):27-36. PubMed ID: 17547562
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide infusion alleviates cellular activation during preparation, leukofiltration and storage of platelets.
Wong K; Li X
Transfus Apher Sci; 2004 Feb; 30(1):29-39. PubMed ID: 14746819
[TBL] [Abstract][Full Text] [Related]
6. Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates.
Perez-Pujol S; Tonda R; Lozano M; Fuste B; Lopez-Vilchez I; Galan AM; Li J; Goodrich R; Escolar G
Transfusion; 2005 Jun; 45(6):911-9. PubMed ID: 15934989
[TBL] [Abstract][Full Text] [Related]
7. Platelet concentrates from fresh or overnight-stored blood, an international study.
Dijkstra-Tiekstra MJ; van der Meer PF; Cardigan R; Devine D; Prowse C; Sandgren P; de Wildt-Eggen J;
Transfusion; 2011 Jan; 51 Suppl 1():38S-44S. PubMed ID: 21223294
[TBL] [Abstract][Full Text] [Related]
8. In vitro function of buffy coat-derived platelet concentrates stored for 9 days in CompoSol, PASII or 100% plasma in three different storage bags.
Cardigan R; Sutherland J; Garwood M; Bashir S; Turner C; Smith K; Hancock V; Wiltshire M; Pergande C; Williamson LM
Vox Sang; 2008 Feb; 94(2):103-12. PubMed ID: 18034786
[TBL] [Abstract][Full Text] [Related]
9. Current status of additive solutions for platelets.
Alhumaidan H; Sweeney J
J Clin Apher; 2012; 27(2):93-8. PubMed ID: 22298435
[TBL] [Abstract][Full Text] [Related]
10. Platelet additive solutions: a future perspective.
van der Meer PF
Transfus Clin Biol; 2007 Dec; 14(6):522-5. PubMed ID: 18420439
[TBL] [Abstract][Full Text] [Related]
11. The use of inhibitors of platelet activation or protease activity in platelet concentrates stored for transfusion.
Bode AP; Norris HT
Blood Cells; 1992; 18(3):361-80; discussion 381-2. PubMed ID: 1337481
[TBL] [Abstract][Full Text] [Related]
12. Effects of immediate or delayed addition of platelet additive solution on the in vitro quality of apheresis platelets.
Ringwald J; Tully S; Geier C; Hauck B; Weiss D; Callaert M; Eckstein R
Transfusion; 2012 Jun; 52(6):1237-44. PubMed ID: 22070790
[TBL] [Abstract][Full Text] [Related]
13. [Properties of stored platelet concentrates: effect of the suspension media and type of pouch used].
Castrillo A; Castro A; Cid J; Adelantado M; Eiras A; Flores J; Solla E; Varela J; García-Villaescusa R
Sangre (Barc); 1999 Oct; 44(5):315-8. PubMed ID: 10618906
[TBL] [Abstract][Full Text] [Related]
14. Impact of glucose and acetate on the characteristics of the platelet storage lesion in platelets suspended in additive solutions with minimal plasma.
Saunders C; Rowe G; Wilkins K; Collins P
Vox Sang; 2013 Jul; 105(1):1-10. PubMed ID: 23347286
[TBL] [Abstract][Full Text] [Related]
15. Effect of additive solutions on platelet biochemistry.
Holme S
Blood Cells; 1992; 18(3):421-30; discussion 431-4. PubMed ID: 1286196
[TBL] [Abstract][Full Text] [Related]
16. Storage of buffy-coat-derived platelets in additive solutions: in vitro effects on platelets stored in reformulated PAS supplied by a 20% plasma carry-over.
Sandgren P; Mayaudon V; Payrat JM; Sjödin A; Gulliksson H
Vox Sang; 2010 Apr; 98(3 Pt 2):415-22. PubMed ID: 19788514
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo effects of potassium and magnesium on storage up to 7 days of apheresis platelet concentrates in platelet additive solution.
Diedrich B; Sandgren P; Jansson B; Gulliksson H; Svensson L; Shanwell A
Vox Sang; 2008 Feb; 94(2):96-102. PubMed ID: 18034788
[TBL] [Abstract][Full Text] [Related]
18. Activation of platelet concentrate during preparation and storage.
Rinder HM; Snyder EL
Blood Cells; 1992; 18(3):445-56; discussion 457-60. PubMed ID: 1283703
[TBL] [Abstract][Full Text] [Related]
19. In vitro storage characteristics of platelet concentrates suspended in 70% SSP+(TM) additive solution versus plasma over a 14-day storage period.
Saunders C; Rowe G; Wilkins K; Holme S; Collins P
Vox Sang; 2011 Aug; 101(2):112-21. PubMed ID: 21414010
[TBL] [Abstract][Full Text] [Related]
20. Extended storage of platelets in SSP platelet additive solution.
Hornsey VS; McColl K; Drummond O; McMillan L; Morrison A; Morrison L; MacGregor IR; Prowse CV
Vox Sang; 2006 Jul; 91(1):41-6. PubMed ID: 16756600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
